Welcome to our dedicated page for Pedevco SEC filings (Ticker: PED), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
PEDEVCO Corp. (NYSE American: PED) files a range of documents with the U.S. Securities and Exchange Commission that give detailed insight into its oil and natural gas business. As a Texas-incorporated, NYSE American–listed energy company, PEDEVCO uses SEC filings to report on its operations in the Permian Basin and Rockies basins, its financial condition, and significant corporate transactions.
Annual reports on Form 10-K and quarterly reports on Form 10-Q contain audited and interim financial statements, production and revenue information, lease operating expenses, depreciation, depletion and amortization, and discussions of non-GAAP measures such as EBITDA and Adjusted EBITDA. These filings also describe the company’s principal assets, including its Permian Basin Asset in eastern New Mexico and its D-J Basin and other Rockies assets.
Current reports on Form 8-K are especially important for tracking material events. For PEDEVCO, recent 8-K and 8-K/A filings document the North Peak Merger, under which PEDEVCO acquired substantial oil-weighted producing assets and leasehold interests in the Northern DJ and Powder River Basins, as well as related Series A Convertible Preferred Stock issuances and amendments to its credit agreement with Citibank. Other 8-K filings cover quarterly earnings press releases, changes in the company’s independent registered public accounting firm, restatements of prior financial statements, and borrowings under its reserve-based lending facility.
Investors interested in capital structure and governance can review filings describing the terms of the Series A Convertible Preferred Stock, board composition changes, and shareholder voting results from proxy materials such as the Definitive Proxy Statement on Schedule 14A. These documents outline nomination rights, board committee assignments, and equity incentive plans.
On this page, Stock Titan surfaces PEDEVCO’s SEC filings as they are posted to EDGAR and provides AI-powered summaries to explain the context and key points of each document. Users can quickly see how new 8-Ks, 10-Qs, 10-Ks, and related exhibits affect PEDEVCO’s production profile, Rockies-focused strategy, credit facility usage, and preferred and common equity structure.
PEDEVCO (PED) reported insider activity for its President and CEO, who also serves as a director. On 10/31/2025, he was granted 2,000,000 shares of restricted common stock at $0, issued for services. 1,000,000 of these vest time‑based: one‑third on each of the first, second, and third anniversaries of the Closing Date. Up to 1,000,000 vest upon a price trigger if the 30‑day average closing price reaches at least $0.90 within four years after the Closing Date, following the schedule described; unvested shares are forfeited if the trigger is not met.
Following the transactions, the reporting person beneficially owned 3,577,133 common shares (direct). He also acquired 45,455 shares of Series A Convertible Preferred Stock (indirect via American Resources, Inc.) that automatically convert 10‑for‑1 into common stock on the Automatic Conversion Date after a 20‑day information statement period following approval that occurred on 10/31/2025, representing 454,550 underlying common shares. The reported price of the derivative security was $5.5.
PEDEVCO (PED) reported insider equity awards on a Form 4 for its Chief Commercial Officer. On October 31, 2025, the officer received 300,000 shares of restricted common stock at $0 in consideration for services. These shares vest in three equal tranches on the one-, two-, and three-year anniversaries of the merger closing on October 31, 2025, subject to continued service.
The filing also reports 4,546 shares of Series A Convertible Preferred Stock, which automatically convert 10-for-1 into common stock after a 20-day period following distribution of an information statement under Rule 14c-2 that disclosed majority stockholder approval on October 31, 2025. The form lists a $5.5 price for the derivative security. Following these transactions, the officer beneficially owns 664,118 shares of common stock directly.
Pedevco Corp (PED) director John J. Scelfo reported acquiring 100,000 shares of Series A Convertible Preferred Stock on 10/31/2025, indirectly through the John J. Scelfo Revocable Trust. The filing lists a $5.5 price for the derivative security and notes that the preferred automatically converts into common stock at a 10-for-1 ratio on the “Automatic Conversion Date.”
Per the disclosure, the preferred is not convertible until the expiration of a twenty calendar day period commencing on the distribution to shareholders of an information statement under Rule 14c‑2 of Regulation 14C, which discloses, among other things, approval by the majority stockholders on October 31, 2025. The derivative represents 1,000,000 shares of common stock underlying the preferred upon conversion. Following the reported transactions, Scelfo beneficially owned 674,500 shares of common stock directly.
PEDEVCO (PED) Executive VP, General Counsel and Secretary reported equity awards on Form 4. On 10/31/2025, the officer received 500,000 shares of restricted common stock at $0 as compensation tied to the closing of a merger. The award vests 1/3 on each of the first, second, and third anniversaries of the Closing Date, subject to continued service.
The filer also acquired 4,546 shares of Series A Convertible Preferred Stock at $5.5 per preferred share, automatically converting 10-for-1 into 45,460 common shares after the Rule 14c‑2 information statement period. Following these transactions, common stock beneficial ownership was 1,580,334 direct, plus 2,867 indirect via a minor child.
PEDEVCO (PED) closed two mergers with North Peak Oil & Gas and Century Oil & Gas Sub‑Holdings, issuing 10,650,000 shares of new Series A Convertible Preferred Stock that automatically convert 10‑for‑1 into 106,500,000 common shares after the Rule 14c‑2 20‑day notice period. Concurrently, a PIPE added 6,363,637 Series A Preferred that will convert into 63,636,370 common shares.
PEDEVCO also entered an amended and restated credit facility maturing October 31, 2029, with an initial $120 million borrowing base (up to $250 million) and drew $87 million at closing. Hedging covenants require minimum coverage of projected production. Net PIPE proceeds of $35,000,004 were used to repay acquired liabilities and deal costs.
Governance changes include three director appointments and a Series A director right until conversion. Post‑conversion ownership is expected at approximately 14.0% for pre‑conversion securityholders (excluding Dr. Kukes), ~33.1% for Dr. Kukes, and ~52.9% for Juniper and other former owners. Majority shareholders approved an A&R charter, an authorized share increase, and reverse split authority (1‑for‑10 to 1‑for‑20). Registration rights require filing a resale registration within 45 days after the Automatic Conversion Date.
PEDEVCO Corp. (PED) filed Amendment No. 3 to its Annual Report to correct and restate financial statements. The filing fixes an administrative reference in the auditor’s report and confirms a restatement of the 2024, 2023, and 2022 audited financials due to an error in the tax provision that overstated the tax benefit and deferred tax balances. It also reiterates prior corrections for depletion accounting.
Management reports disclosure controls and procedures remained ineffective as of December 31, 2024, and identified an additional material weakness in internal control over financial reporting.
Operationally, 2024 revenue was $39,553,000. Total production reached 671,796 Boe (average 1,835 Boe/d), including 492,396 Bbls of oil at an average price of $73.50/Bbl, 608,382 Mcf of gas at $2.00/Mcf, and 78,003 Bbls of NGLs at $27.48/Bbl. Average production cost was $10.36/Boe. Proved reserves totaled 18.1 million Boe at year-end 2024.
Liquidity tools include a $250 million reserve-based lending facility with an initial $20 million borrowing base and an ATM program up to $8.0 million. As of March 28, 2025, 91,339,385 common shares were outstanding.
PEDEVCO Corp. (PED) filed Amendment No. 2 to its Annual Report, restating audited 2024 financials to correct an error in accounting for prior-period net operating losses that overstated the tax benefit and deferred tax balances. The filing also carries forward prior restatements addressing depletion expense errors in 2023 and 2022.
The company reports disclosure controls and procedures remained ineffective as of December 31, 2024, and identified an additional material weakness in internal control over financial reporting tied to these errors. The amendment updates oil and gas disclosures to align with Regulation S‑K Items 1200–1208.
Operationally, 2024 total revenues were $39,553,000, with total production of 671,796 Boe at average production costs of $10.36 per Boe. Proved reserves were 18.1 million Boe, including 14.2 million Bbls of crude oil and NGLs and 23.4 million Mcf of natural gas. For 2025, planned capital expenditures are $27–$33 million, with 70%–75% allocated to the D‑J Basin under joint development arrangements. The company entered a $250 million reserve‑based lending facility with a $20 million initial borrowing base, undrawn to date. As of March 28, 2025, 91,339,385 common shares were outstanding.
PEDEVCO Corp. (PED) announced a non‑reliance and restatement of its audited financial statements for the year ended December 31, 2024, after its Audit Committee identified an error in accounting for prior period net operating losses in the tax provision. The company stated the error overstated the tax benefit and deferred income tax account by approximately $5.5 million for 2024.
PEDEVCO noted the correction will reduce net income and lower earnings to $0.14 per basic and diluted share from $0.20 for 2024. The company emphasized there was no impact on cash position, cash flow, revenues, or liquidity. Management also identified additional material weaknesses in internal control over financial reporting and disclosure controls as of December 31, 2024, and is developing a remediation plan.
The company is preparing an amended Annual Report on Form 10‑K for 2024 that will include restated financial statements and related disclosures.
PEDEVCO Corp. director H. Douglas Evans received 140,000 restricted shares on 08/28/2025, bringing his total beneficial ownership to 600,000 common shares. The shares were issued under the companys 2021 Equity Incentive Plan in consideration for board services and are subject to forfeiture until they fully vest on September 27, 2026, conditional on continued board membership and the terms of a Restricted Shares Grant Agreement. The award is reported as exempt under Rule 16b-3(d). The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
PEDEVCO Corp. reporting persons filed a Form 4 disclosing issuance of 200,000 restricted shares to Simon G. Kukes on 08/28/2025 as compensation for board services at a reported price of $0. The restricted shares were granted under the issuer's 2021 Equity Incentive Plan and are subject to forfeiture until they fully vest on January 1, 2026, conditional on Kukes remaining a director and the terms of a Restricted Shares Grant Agreement. The filing shows beneficial ownership following the transaction of 8,121,950 shares (direct), 51,791,325 shares (indirect) through The SGK 2018 Revocable Trust, and 3,000 shares (indirect) held by spouse. Reporting roles include Executive Chairman and Chief Executive Officer for the respective reporting persons. The filing is presented as exempt under Rule 16b-3(d) and includes usual attorney-in-fact signatures.
FAQ
What is the current stock price of Pedevco (PED)?
What is the market cap of Pedevco (PED)?
